Sofinnova Venture Partners Ix, L.P. Insider Trades

Insider Trading History

Track insider trading activity for Sofinnova Venture Partners Ix, L.P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
10% owner
Holding Value $36.8k 1,226,514 shares
Last Trade
Jun 02, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.72M 400,000 shares
$24.30
$0.03
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
10% owner
Holding Value $48.8k 1,626,514 shares
Last Trade
Jun 01, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.55M 100,000 shares
$25.50
$0.03
Nextcure
Nextcure NXTC
10% owner
Holding Value $8.52M 2,671,856 shares
Last Trade
Nov 15, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$64.9M 150,000 shares
$432.60
$3.19
Galera Therapeutics
Galera Therapeutics GRTX
10% owner
Holding Value $233k 2,333,712 shares
Last Trade
Nov 12, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$30.5M 2,333,712 shares
$13.05
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
10% owner
Holding Value $308k 3,083,712 shares
Last Trade
Nov 12, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9M 750,000 shares
$12.00
$0.10
Nextcure
Nextcure NXTC
10% owner
Holding Value $8.04M 2,521,856 shares
Last Trade
May 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$93.1M 400,000 shares
$232.80
$3.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
10% owner
Holding Value $0 0 shares
Last Trade
Sep 28, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$81M 7,446,904 shares
$10.88
$2.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
10% owner
Holding Value $2.58M 1,180,178 shares
Last Trade
Sep 28, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.67M 337,724 shares
$10.88
$2.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
10% owner
Holding Value $0 0 shares
Last Trade
Sep 25, 2018 Sale
No data
No data
$2.19
Entasis Therapeutics Holdings
Entasis Therapeutics Holdings ETTX
10% owner
Holding Value $0 0 shares
Last Trade
Sep 25, 2018 Sale
No data
No data
$2.19
Iterum Therapeutics Plc
Iterum Therapeutics Plc ITRM
10% owner
Holding Value $51.8k 1,726,514 shares
Last Trade
May 30, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$91.1M 500,000 shares
$182.25
$0.03
Atyr Pharma
Atyr Pharma LIFE
10% owner
Holding Value $0 0 shares
Last Trade
May 12, 2015 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$4.52B 14,968,722 shares
$301.98
$17.18
Atyr Pharma
Atyr Pharma LIFE
10% owner
Holding Value $26.6M 1,546,126 shares
Last Trade
May 12, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$467M 1,546,126 shares
$301.98
$17.18
Atyr Pharma
Atyr Pharma LIFE
10% owner
Holding Value $32.1M 1,866,126 shares
Last Trade
May 12, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$96.6M 320,000 shares
$301.98
$17.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up